close 74% of retail accounts lose money when trading CFDs with this provider. Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 74% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
SearchSearch
Change languageEnglish (International)
Dashboard

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

Home・Stock List・Jazz Pharmaceuticals PLC
Search

Jazz Pharmaceuticals PLC

Open

SectorHealthcare

121.02 -4.27

Strong Buy

Price update 3 Apr 2025, 17:51 UTC

BuySell

Overview

Share price change

24h

Current

Min

119.71

Max

127.67

Key metrics

By Trading Economics

Income

-24M

191M

Sales

33M

1.1B

P/E

Sector Avg

14.205

63.778

EPS

6.6

Profit margin

17.563

Employees

2,800

EBITDA

-234M

191M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+55.07% upside

Dividends

By Dow Jones

Next Earnings

30 Apr 2025

Market Stats

By TradingEconomics

Market Cap

-724M

7.5B

Previous open

125.29

Previous close

121.02

News Sentiment

By Acuity

50%

50%

180 / 386 Healthcare

Technical Score

By Trading Central

Confidence

Very Strong Bearish Evidence

122.83 / 142.64 Support & Resistance

Jazz Pharmaceuticals PLC Chart

Past performance is not a reliable indicator of future results.

Related News

21 Nov 2024, 14:45 UTC

Major Market Movers

Zymeworks Shares Rise 8.3% After Licensed Cancer Treatment Gets FDA OK

DJ

Read

31 Oct 2024, 15:29 UTC

Major Market Movers

Avadel Pharma Shares Rise on Favorable Ruling for FDA in Lumryz Litigation

DJ

Read

Peer Comparison

Price change

Jazz Pharmaceuticals PLC Forecast

Price Target

By TipRanks

55.07% upside

12 Months Forecast

Average 193.82 USD  55.07%

High 230 USD

Low 150 USD

Based on 18 Wall Street analysts offering 12 month price targets forJazz Pharmaceuticals PLC - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

18 ratings

17

Buy

1

Hold

0

Sell

Based on 18 analysts giving stock ratings to Jazz Pharmaceuticals PLC - Dist in the past 3 months.

Technical Score

By Trading Central

122.83 / 142.64Support & Resistance

Short Term

Very Strong Bearish Evidence

Bearish events outweigh bullish events.

Intermediate Term

Strong Bearish Evidence

Recent bearish events outweigh bullish events.

Long Term

Bearish Evidence

All events are bearish.

Sentiment

By Acuity

180 / 386 Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

Other stocks from the sector

MDT

Medtronic PLC

87.86

↓-1.21%

VEEV

Veeva Systems Inc

221.66

↓-2.12%

A

Agilent Technologies Inc

109.71

↓-5.41%

HQY

HealthEquity Inc

82.88

↓-6.59%

PDCO

Patterson Cos Inc

31.2

↓-0.22%